Posaconazole Treatment for Apophysomyces elegans Rhino-Orbital Zygomycosis following Trauma for a Male with Well-Controlled Diabetes-Reference-Cited by-同舟云学术

Posaconazole Treatment for Apophysomyces elegans Rhino-Orbital Zygomycosis following Trauma for a Male with Well-Controlled Diabetes

Published:2007-05 Issue:5 Volume:45 Page:1648-1651
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Ferguson T. D.¹,Schniederjan S. D.²,Dionne-Odom J.¹,Brandt M. E.³,Rinaldi M. G.⁴,Nolte F. S.²,Langston A.⁵,Zimmer S. M.¹

Affiliation:

1. Department of Medicine

2. Department of Pathology and Laboratory Medicine

3. Emory University School of Medicine, Atlanta, Georgia; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia

4. Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas

5. Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia

Abstract

ABSTRACT We report a case of rhino-orbital zygomycosis in a 43-year-old male with well-controlled diabetes mellitus. The patient initially received liposomal amphotericin B, but the infection continued to progress, so posaconazole treatment was begun and eventually led to the cure of his infection. The causative agent was identified as Apophysomyces elegans , an emerging cause of zygomycosis in immunocompetent hosts.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00014-07

Reference19 articles.

1. Chayakulkeeree, M., M. A. Ghannoum, and J. R. Perfect. 2006. Zygomycosis: the re-emerging fungal infection. Eur. J. Clin. Microbiol. Infect. Dis.25:215-229.

2. Cornely, O., J. Maertens, D. Winston, J. Perfect, D. Helfgott, A. Ullmann, J. Holowiecki, D. Stockelberg, Y.-T. Goh, M. Petrini, T. Walsh, J. Gogate, C. Hardalo, and D. Angulo-Gonzalez. 2005. Posaconazole vs standard azole (FLU/ITRA) therapy for prophylaxis of invasive fungal infections (IFIs) among high-risk neutropenic patients: results of a randomized, multicenter trial. Blood106:1844.

3. Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative Study

4. Garcia-Covarrubias, L., R. Bartlett, D. M. Barratt, and R. J. Wassermann. 2001. Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature. J. Trauma50:353-357.

5. Posaconazole as Salvage Therapy for Zygomycosis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases;Mycoses;2022-10-20

2. A Rare Fungal Orbital Infection in an Immunocompetent Young Male Caused by Lichtheimia corymbifera (Absidia corymbifera);Ocular Immunology and Inflammation;2021-06-10

3. Chronic orbital and calvarial fungal infection with Apophysomyces variabilis in an immunocompetent patient;Survey of Ophthalmology;2017-01

4. Primary Cutaneous Mucormycosis Produced by the New Species Apophysomyces mexicanus;Journal of Clinical Microbiology;2014-10-08

5. Mucormycosis treated with posaconazole: review of 96 case reports;Critical Reviews in Microbiology;2012-08-24